NCT06233643

Brief Summary

The goal of this clinical trial is to compare the analgesic effect and tolerance profile of acupuncture combined with intradermal sterile water application versus intramuscular phloroglucinol in acute renal colic. In this study, we aimed primarily to test the efficacy of acupuncture combined with intradermal sterile water application as a rapid and effective treatment in severe renal colic. Participants will randomly divided into two groups. The first group received only intramuscular phloroglucinol, the second group received acupuncture and intradermal sterile water.The visual analog scale (VAS,ranging from 0 for no pain to 10 for maximum imaginable pain) was used to assess pain intensity at baseline and at 10, 20, 30, 45,and 60 minutes following the start of the treatment protocol. Possible treatment side effects were also recorded.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 31, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

Same day

First QC Date

January 13, 2024

Last Update Submit

January 27, 2024

Conditions

Keywords

AcupunctureIntradermal Sterile WaterNSAIDS

Outcome Measures

Primary Outcomes (2)

  • Baseline characteristics of patients

    Baseline characteristics of patients between two groups concerning age (years), sex (male or female ), and baseline VAS score (ranging from 0 for no pain to 10 for maximum imaginable pain)

    before treatment

  • primary outcome

    Visual analogue scale (VAS, ranging from 0 for no pain to 10 for maximum imaginable pain) will be used to assess pain intensity after 10, 30, 60, and 120 minutes.

    10, 30, 60, and 120 minutes after treatment.

Secondary Outcomes (1)

  • side effects

    in 120 minutes after treatment.

Study Arms (2)

The group received acupuncture combined with intradermal sterile water

EXPERIMENTAL

These acute renal colic patients who will received acupuncture combined with intradermal sterile water

Combination Product: Acupuncture Combined Intradermal Sterile Water

The group received intramuscular inject phloroglucinol

ACTIVE COMPARATOR

These acute renal colic patients who will received intramuscular inject phloroglucinol.

Drug: Phloroglucinol

Interventions

The active comparators will be treated with 40 mg of Phloroglucinol in the form of a single intramuscular injection.

The group received intramuscular inject phloroglucinol

Acupuncture was applied to a seated patient using the urinary bladder meridian points and combianed Intradermal Sterile Water in costovertebral area where the patient's pain was located (Sterile water of 0.5 ml was injected as intradermal into 4 points at a depth of 1-3 mm to form papules)

The group received acupuncture combined with intradermal sterile water

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Renal Colic

Interventions

Phloroglucinol

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urologist of Third BUCM,MD

Study Record Dates

First Submitted

January 13, 2024

First Posted

January 31, 2024

Study Start

February 1, 2024

Primary Completion

February 1, 2024

Study Completion

January 31, 2025

Last Updated

January 31, 2024

Record last verified: 2024-01